BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33146708)

  • 1. Studies on the changes of uPA system in a co-culture model of bone marrow stromal cells-leukemia cells.
    Zhou L; Guo H; Jia F; Chen X; Zhang X; Dong S; Zhao L
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. uPA and MMP-2 were involved in self-assembled network formation in a two dimensional co-culture model of bone marrow stromal cells and endothelial cells.
    Li H; Daculsi R; Bareille R; Bourget C; Amedee J
    J Cell Biochem; 2013 Mar; 114(3):650-7. PubMed ID: 23059760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
    Baker EA; Bergin FG; Leaper DJ
    Mol Pathol; 2000 Dec; 53(6):307-12. PubMed ID: 11193049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cells enhance self-assembly of a HUVEC tubular network through uPA-uPAR/VEGFR2/integrin/NOTCH crosstalk.
    Beloglazova I; Stepanova V; Zubkova E; Dergilev K; Koptelova N; Tyurin-Kuzmin PA; Dyikanov D; Plekhanova O; Cines DB; Mazar AP; Parfyonova Y
    Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119157. PubMed ID: 34619163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and localization of urokinase-type plasminogen activator receptor in bovine cumulus-oocyte complexes.
    García DC; Miceli DC; Rizo G; García EV; Valdecantos PA; Roldán-Olarte M
    Zygote; 2016 Apr; 24(2):230-5. PubMed ID: 25939353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-initiated angiogenesis and the uPA/uPAR system.
    Breuss JM; Uhrin P
    Cell Adh Migr; 2012; 6(6):535-615. PubMed ID: 23076133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.
    Hildenbrand R; Schaaf A; Dorn-Beineke A; Allgayer H; Sütterlin M; Marx A; Stroebel P
    Histol Histopathol; 2009 Jul; 24(7):869-77. PubMed ID: 19475533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in uPA, PAI-1, and TGF-β Production during Breast Cancer Cell Interaction with Human Mesenchymal Stroma/Stem-Like Cells (MSC).
    Melzer C; von der Ohe J; Otterbein H; Ungefroren H; Hass R
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31142059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of uPA, uPAR, and PAI-1 in psoriatic skin and in basal cell carcinomas.
    Rubina KA; Sysoeva VY; Zagorujko EI; Tsokolaeva ZI; Kurdina MI; Parfyonova YV; Tkachuk VA
    Arch Dermatol Res; 2017 Aug; 309(6):433-442. PubMed ID: 28429105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and activation of proteases in co-cultures.
    Paduch R; Kandefer-Szerszeń M
    Exp Toxicol Pathol; 2011 Jan; 63(1-2):79-87. PubMed ID: 19836935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
    Fox SB; Taylor M; Grøndahl-Hansen J; Kakolyris S; Gatter KC; Harris AL
    J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages of M1 phenotype have properties that influence lung cancer cell progression.
    Hedbrant A; Wijkander J; Seidal T; Delbro D; Erlandsson A
    Tumour Biol; 2015 Nov; 36(11):8715-25. PubMed ID: 26050228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
    BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen Activation System in Rectal Adenocarcinoma.
    Razik E; Kobierzycki C; Grzegrzolka J; Podhorska-Okolow M; Drag-Zalesinska M; Zabel M; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6009-15. PubMed ID: 26504024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of vascular actors in two dimensional dialogue of human bone marrow stromal cell and endothelial cell for inducing self-assembled network.
    Li H; Daculsi R; Grellier M; Bareille R; Bourget C; Remy M; Amedee J
    PLoS One; 2011 Feb; 6(2):e16767. PubMed ID: 21304816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma.
    Nakanishi K; Kawai T; Torikata C; Aurues T; Ikeda T
    Cancer; 1998 Feb; 82(4):724-32. PubMed ID: 9477106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.